Abstract: The present invention relates to a novel process for producing metal composites by internal oxidation.

Abstract: A polarization beam splitter selectively decouples detection light onto a detector such that it has a polarization direction that differs from the emitted illumination light. This enables the detection of the light scattered back in the eye lens at a high level of accuracy, since stray light from reflections at optical components of the light path is suppressed. In the generating of photo disruptions or other incisions, the ray exposure of the retina may be reduced in that the incisions being furthest away from the laser are induced first such that laminar gas inclusions with an existence duration time of at least 5 seconds result. In this manner the laser radiation propagated in the direction of the retina in further incisions are scattered and partially reflected such that the influence impinging upon the retina is reduced.

Abstract: A method for operating an internal combustion engine having two or more cylinders to which fuel can be supplied via an injection valve, it being possible to carry out a measurement injection for a cylinder in order to determine and/or adapt a characteristic quantity of the injection valve, and all the cylinders being ignited in the course of an ignition cycle. To improve the operating characteristics, a measurement injection is carried out for those cylinders that are contained in a specifiable selected set selected from all the cylinders.

Abstract: A transdermal therapeutic system (TTS) that is essentially composed of two compartments and is provided with activatable oversaturation and controlled permeation promotion. The invention more particularly relates to a TTS wherein an oversaturated active ingredient solution is produced in an active-substance-containing polymer matrix when the system is applied to the skin, caused by the controlled supply of one or several substances promoting the permeation of the pharmaceutical active ingredient; to the two compartments from which the inventive transdermal therapeutic system is assembled; and to the production of the transdermal therapeutic system from the two compartments.

Abstract: A method for assessing an injection behavior of at least one injection valve of an internal combustion engine includes putting the internal combustion engine into a special operating mode defined by control parameters and operating the engine in the special operating mode during a diagnostic time period, at least one operating parameter of the internal combustion engine being determined at least during the diagnostic time period, and at least one quantity characterizing the injection behavior of the at least one injection valve being evaluated at least during a segment of the diagnostic time period and being evaluated on the basis of the at least one operating parameter.

Abstract: The embodiments relate to a capacitor device for a conductor loop in a device for the in-situ production of heavy oil and bitumen from oil-sand deposits, characterized by a housing and a capacitor unit arranged therein to compensate for the inductive voltage drop along the conductor loop, wherein there are two connection interfaces, wherein each connection interface is designed for mechanical and electrically conductive connection between the capacitor unit and a conductor element of the conductor loop.

Abstract: The invention relates to a method for coating an insulation component (10), having PEEK, for insulating an electrically conductive heating cable (100) comprising the following steps: 1.) at least sectionally treating the surface of the insulation component (10) with at least one cold plasma flame, and 2.) applying at least one protective layer (20) to the treated surface of the insulation component (10).

Abstract: A method for activating an injector in a fuel injection system in an internal combustion engine, the fuel injection system including a plurality of injectors and a quantity of fuel injected with the aid of an injector being a function of the activation period of the injector. An injector-individual correction value for the activation period is ascertained for at least one injector as a function of a pressure and a temperature of the fuel to be injected and the activation for this injector takes place under consideration of the injector-individual correction value.

Abstract: The present invention relates to a novel process for producing metal composites by internal oxidation.

Abstract: A can annular combustion arrangement (12) for a gas turbine engine (10), including: a combustor can (14) having an inlet (46) at a head end (62); an annular chamber (30) surrounding the combustor can (14) for delivering a flow of compressed air from a plenum (18) to the inlet (46); a fuel injector (49) configured to inject a flow of fuel into the flow of compressed air; and a flow tripping device (60) surrounding the combustor can (14) and disposed in the annular chamber (30) downstream of the fuel injector (49).

Abstract: The invention is a method and apparatus for forming a relief structure by thermally developing a photosensitive element containing a composition layer capable of being partially liquefied. During thermal development, the photosensitive element is supported on a base member having an exterior surface that is textured. The textures for the exterior surface include a particular surface roughness and/or patterns.

Abstract: A method for preparing compounds of the formula (I) by the cyclization of tetraacetic acid alkyl esters of the formula (II) in the presence of ammonia and formamide as well as to the compounds of the formula (II), which are used in this method.

Abstract: A transdermal therapeutic system for administering lipophilic, poorly water-soluble and/or sparingly skin-permeable pharmaceutical active substances. The active substance is present in a multi-component enhancer system consisting of 4 components and each component of the multi-component enhancer system is selected from a different one of the substance groups: a) terpenes, b) cyclic glucitol ethers, c) medium-chain triglycerides of capric and caprylic acid and/or of linoleic acid; and d) longer-chain alcohols having a chain length of 8 or more carbon atoms.

Abstract: A transdermal therapeutic system for administering lipophilic, poorly water-soluble and/or sparingly skin-permeable pharmaceutical active substances. The active substance is present in a multi-component enhancer system consisting of 4 components and each component of the multi-component enhancer system is selected from a different one of the substance groups: a) terpenes, b) cyclic glucitol ethers, c) medium-chain triglycerides of capric and caprylic acid and/or of linoleic acid; and d) longer-chain alcohols having a chain length of 8 or more carbon atoms.

Abstract: A pressure sensitive adhesive for medicinal application purposes, based on ethylene-vinyl acetate copolymers is characterized in that it contains as polymer component (A) an ethylene-vinyl acetate copolymer or a combination of at least two ethylene-vinyl acetate copolymers, and as component (B) an adhesive resin or a combination of adhesive resins at a portion of up to 55%-wt, relative to the sum of components (A) and (B) without active substances or other auxiliary substances.

Abstract: A method for operating an internal combustion engine, in particular, of a motor vehicle. The internal combustion engine includes an injector having a nozzle needle for injecting fuel into a combustion chamber of the internal combustion engine, as well as an output stage component. A desired signal is specified for a lift characteristic of the nozzle needle. The injector is activated by the output stage component. A lift signal is ascertained that corresponds to the actual lift characteristic of the nozzle needle. An actual signal is ascertained from the lift signal. A deviation signal is ascertained in response to a deviation of the actual signal from the desired signal.

Abstract: The invention relates to N-hydroxylated amidines, guanidines and aminohydrazones for application on the skin. In particular, the invention relates to transdermal therapeutic systems containing N-hydroxylated amidines, guanidines and aminohydrazones as a prodrug, and to methods for producing and using such systems.

Abstract: The present invention relates to an iontophorectic device and a composition comprising active ingredients for the transdermal release of active ingredients, particularly of human insulin. Insulin, a blood sugar-lowering hormone inhibiting glycogen breakdown of the pancreas, can be made available as the most important pharmaceutical for the therapy of diabetes mellitus via the transdermal resorption route.

Abstract: A polarization beam splitter selectively decouples detection light onto a detector such that it has a polarization direction that differs from the emitted illumination light. This enables the detection of the light scattered back in the eye lens at a high level of accuracy, since stray light from reflections at optical components of the light path is suppressed. In the generating of photo disruptions or other incisions, the ray exposure of the retina may be reduced in that the incisions being furthest away from the laser are induced first such that laminar gas inclusions with an existence duration time of at least 5 seconds result. In this manner the laser radiation propagated in the direction of the retina in further incisions are scattered and partially reflected such that the influence impinging upon the retina is reduced.

Abstract: A composition for transdermal delivery, particularly iontophoretic transdermal delivery, having at least one cationic active agent or a salt thereof. The composition comprises at least one cationic active agent or a salt thereof, at least one polyamine and/or polyamine salt, water or an aqueous solvent mixture, and optionally one or more additives. Use of the composition as a component of a transdermal patch or of an iontophoretic transdermal patch is also provided, as well as the use of the composition in a method for transdermally or iontophoretically administering cationic active agents. A method for determining the in vitro skin permeation properties of an active agent-containing iontophoretic composition is also provided.